Pre-eclampsia is a common, pregnancy-induced disorder, consisting of hypertension and proteinuria. The condition is one of the leading causes for maternal and perinatal morbidity and mortality. Nonetheless, the underlying molecular mechanisms remain unclear. Immunological mechanisms and the renin-angiotensin system have been implicated in the development of pre-eclampsia. Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) have been identified in pre-eclamptic patients, unifying the two hypothesis. Evidence has also accumulated for the existence and importance of a local, utroplacental renin-angiotensin system. We summarize recent data emphasizing the pathophysiological role for the autoantibodies and the uteroplacental ...
Pregnant women who subsequently develop preeclampsia are highly sensitive to infused angiotensin (An...
Abnormal uterine perfusion detected by Doppler sonography reflects impaired trophoblast invasion, a ...
Abstract-We showed earlier that activating autoantibodies against the angiotensin II type 1 (AT 1 ) ...
Pre-eclampsia is a common, pregnancy-induced disorder, consisting of hypertension and proteinuria. T...
The renin-angiotensin system (RAS) participates in preeclampsia; however, the relative contributions...
Autoantibodies can cause complications in pregnancy. Preeclampsia is the leading cause of maternal a...
Autoantibodies can cause complications in pregnancy. Preeclampsia is the leading cause of maternal a...
Preeclampsia is a disease that affects 3–5% of all pregnancies. The cause is unknown and there is cu...
Preeclampsia (PE) is a disease of late pregnancy characterized by maternal hypertension and proteinu...
Preeclampsia (PE), a syndrome affecting 5% of pregnancies, characterized by hypertension and protein...
Preeclampsia is a disease that affects 3–5% of all pregnancies. The cause is unknown and there is cu...
Immunologic mechanisms and putatively circulating mediators of preeclampsia are not a new idea, but ...
Abstract—Preeclampsia (PE), a syndrome affecting 5 % of pregnancies, characterized by hypertension a...
Preeclampsia remains a leading cause of maternal and neonatal morbidity and mortality. The pathophys...
Abstract—Preeclampsia is a prevalent life-threatening hypertensive disorder of pregnancy for which t...
Pregnant women who subsequently develop preeclampsia are highly sensitive to infused angiotensin (An...
Abnormal uterine perfusion detected by Doppler sonography reflects impaired trophoblast invasion, a ...
Abstract-We showed earlier that activating autoantibodies against the angiotensin II type 1 (AT 1 ) ...
Pre-eclampsia is a common, pregnancy-induced disorder, consisting of hypertension and proteinuria. T...
The renin-angiotensin system (RAS) participates in preeclampsia; however, the relative contributions...
Autoantibodies can cause complications in pregnancy. Preeclampsia is the leading cause of maternal a...
Autoantibodies can cause complications in pregnancy. Preeclampsia is the leading cause of maternal a...
Preeclampsia is a disease that affects 3–5% of all pregnancies. The cause is unknown and there is cu...
Preeclampsia (PE) is a disease of late pregnancy characterized by maternal hypertension and proteinu...
Preeclampsia (PE), a syndrome affecting 5% of pregnancies, characterized by hypertension and protein...
Preeclampsia is a disease that affects 3–5% of all pregnancies. The cause is unknown and there is cu...
Immunologic mechanisms and putatively circulating mediators of preeclampsia are not a new idea, but ...
Abstract—Preeclampsia (PE), a syndrome affecting 5 % of pregnancies, characterized by hypertension a...
Preeclampsia remains a leading cause of maternal and neonatal morbidity and mortality. The pathophys...
Abstract—Preeclampsia is a prevalent life-threatening hypertensive disorder of pregnancy for which t...
Pregnant women who subsequently develop preeclampsia are highly sensitive to infused angiotensin (An...
Abnormal uterine perfusion detected by Doppler sonography reflects impaired trophoblast invasion, a ...
Abstract-We showed earlier that activating autoantibodies against the angiotensin II type 1 (AT 1 ) ...